Literature DB >> 12626554

A threshold for central T cell tolerance to an inducible serum protein.

Dipica Haribhai1, Deborah Engle, Michelle Meyer, David Donermeyer, J Michael White, Calvin B Williams.   

Abstract

We report an inducible system of self Ag expression that examines the relationship between serum protein levels and central T cell tolerance. This transgenic approach is based on tetracycline-regulated expression of a secreted form of hen egg lysozyme, tagged with a murine hemoglobin (Hb) epitope. In the absence of the tetracycline-regulated transactivator, serum levels of the chimeric protein are extremely low (< or = 0.1 ng/ml) and the mice show partial tolerance to both Hb(64-76) and lysozyme epitopes. In the presence of the transactivator, expression increases to 1.5 ng/ml and the mice are completely tolerant. Partial tolerance was further investigated by crossing these mice to strains expressing transgenic TCRs. At the lowest Ag levels, 3.L2tg T cells (specific for Hb(64-76)/I-E(k)) escape the thymus and approximately 10% of CD4(+) splenocytes express the 3.L2 TCR. In contrast, 3A9 T cells (specific for hen egg lysozyme(46-61)/I-A(k)) are completely eliminated by negative selection. These data define a tolerogenic threshold for negative selection of Ag-specific T cells by circulating self proteins that are 100-fold more sensitive than previously demonstrated. They suggest that partial tolerance at extremely low levels of self Ag exposure is the result of a restricted repertoire of responding T cells, rather than a simple reduction in precursor frequency; tolerogenic thresholds are T cell specific.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12626554     DOI: 10.4049/jimmunol.170.6.3007

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Design and characterization of an APC-specific serpin for the treatment of hemophilia.

Authors:  Stéphanie G I Polderdijk; Ty E Adams; Lacramioara Ivanciu; Rodney M Camire; Trevor P Baglin; James A Huntington
Journal:  Blood       Date:  2016-10-27       Impact factor: 22.113

2.  Neutralizing antibodies to therapeutic enzymes: considerations for testing, prevention and treatment.

Authors:  Jinhai Wang; Jay Lozier; Gibbes Johnson; Susan Kirshner; Daniela Verthelyi; Anne Pariser; Elizabeth Shores; Amy Rosenberg
Journal:  Nat Biotechnol       Date:  2008-08       Impact factor: 54.908

3.  Affinity-based selection of regulatory T cells occurs independent of agonist-mediated induction of Foxp3 expression.

Authors:  Lance M Relland; Manoj K Mishra; Dipica Haribhai; Brandon Edwards; Jennifer Ziegelbauer; Calvin B Williams
Journal:  J Immunol       Date:  2009-02-01       Impact factor: 5.422

4.  Insufficient autoantigen presentation and failure of tolerance in a mouse model of rheumatoid arthritis.

Authors:  Jason Perera; Xiao Liu; Yuzhen Zhou; Nora E Joseph; Liping Meng; Jerrold R Turner; Haochu Huang
Journal:  Arthritis Rheum       Date:  2013-11

Review 5.  Mouse Models for Assessing Protein Immunogenicity: Lessons and Challenges.

Authors:  Wim Jiskoot; Grzegorz Kijanka; Theodore W Randolph; John F Carpenter; Atanas V Koulov; Hanns-Christian Mahler; Marisa K Joubert; Vibha Jawa; Linda O Narhi
Journal:  J Pharm Sci       Date:  2016-04-01       Impact factor: 3.534

6.  Platelet Gene Therapy Promotes Targeted Peripheral Tolerance by Clonal Deletion and Induction of Antigen-Specific Regulatory T Cells.

Authors:  Xiaofeng Luo; Juan Chen; Jocelyn A Schroeder; Kenneth P Allen; Christina K Baumgartner; Subramaniam Malarkannan; Jianda Hu; Calvin B Williams; Qizhen Shi
Journal:  Front Immunol       Date:  2018-09-06       Impact factor: 7.561

Review 7.  Beyond humanization and de-immunization: tolerization as a method for reducing the immunogenicity of biologics.

Authors:  Anne S De Groot; Frances Terry; Leslie Cousens; William Martin
Journal:  Expert Rev Clin Pharmacol       Date:  2013-11       Impact factor: 5.045

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.